Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NKTR | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | KIAA1468 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | RFX7 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | FGF9 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | AC090094.1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | ZNF195 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |